From eNewsletter 7/10/2019
DID YOU KNOW that even a short stay for travelers in cities with high levels of air pollution leads to breathing problems that can take at least a week from which to recover?
A new study in the Journal of Travel Medicine is the first of its kind to analyze pollution-related coughing and breathing difficulties, and recovery times upon returning home, in healthy, young adults traveling internationally.
The subjects were from the New York City area visiting family in cities with consistently high levels of air pollution, including Ahmedabad and New Delhi, India; Rawalpindi, Pakistan; and Xian, China. Some destinations studied -- Beijing, Shanghai, and Milan -- are heavily polluted during certain months but have relatively cleaner air at other times. Other, mostly European, destinations such as Geneva, London; San Sebastien, Spain; Copenhagen; Prague; Stockholm; Oslo; and Reykjavik had consistently lower levels of air pollution.
The research team noted that New York City has relatively low levels of air pollution, in part because of strict regulations, its location on the coast, and weather patterns.
METAGENICS UPS THE ANTE ON QUALITY
As an advocate for high-quality standards, Metagenics is the first practitioner-exclusive supplement brand in the US to give online visibility to quality testing information for every single formula we create. Try it here.
IF ANTIBIOTICS STOP WORKING: PART 1
Steve & Bonnie: New research has found that Cannnabidiol (CBD) is active against Gram-positive bacteria, including those responsible for many serious infections (such as Staphyloccocus aureus and Streptococcus pneumoniae), with potency similar to that of established antibiotics such as vancomycin or daptomycin. The research was presented at the 2019 annual meeting of the American Society for Microbiology.
Cannabidiol, the main non-psychoactive chemical compound extracted from cannabis and hemp plants, has been approved by FDA for the treatment of a form of epilepsy, and is being investigated for a number of other medical conditions, including, anxiety, pain and inflammation.
Researchers found that Cannabidiol was remarkably effective at killing a wide range of bacteria, including bacteria that have become resistant to other antibiotics, and did not lose effectiveness after extended treatment. The combination of inherent antimicrobial activity and potential to reduce damage caused by the inflammatory response to infections is particularly interesting.
Importantly, the drug retained its activity against bacteria that have become highly resistant to other common antibiotics. Under extended exposure conditions that lead to resistance against vancomycin or daptomycin, Cannabidiol did not lose effectiveness. Cannabidiol was also effective at disrupting biofilms, a physical form of bacteria growth that leads to difficult-to-treat infections.
PLEASE NOTE that this study further cements why we do not recommend oral CBD for "everybody". While the possibilities are very exciting, you can see how powerful this substance is. If oral CBD can be this powerful, and you do not need it, the opposite effect of what is desired may occur. CBD must be deemed necessary with a protocol based upon individual needs.
Topical CBD is much safer but still should be used under the auspices of a knowledgable health professional.
IF ANTIBIOTICS STOP WORKING: PART 2
Steve: Public health experts are very concerned that antibiotics-of-last-resort are losing their effectiveness against the most virulent, resistant superbugs...this article is reserved for NCI Well Connect Members. You can get this article by signing up here. You can get our free eNewsletter by signing up at the top of our website.